Readily Diagnostics develops rapid diagnostic tests for infectious diseases using padlock probes and rolling circle amplification, providing results in 15-30 minutes without the need for specialized instruments. Their technology enables accurate detection of pathogens at the point of care, making diagnostics accessible and affordable for healthcare providers.
Funding
$2.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional diagnostic methods for infectious diseases often require specialized laboratory equipment and trained personnel, leading to delays in obtaining results and limiting accessibility in resource-constrained settings. The need for rapid and accurate point-of-care diagnostics is critical for timely treatment and effective disease management.
Solution
Readily Diagnostics offers rapid, instrument-free diagnostic tests for infectious diseases, delivering results in 15-30 minutes. The tests utilize padlock probes and rolling circle amplification (RCA) to achieve high sensitivity and specificity without the need for complex laboratory infrastructure. This technology enables healthcare providers to quickly and accurately detect pathogens at the point of care, facilitating prompt clinical decision-making and improved patient outcomes. The tests can be used for rapid detection of several microorganisms in a sample or as a laboratory test for higher throughput.
Target Audience
The primary target audience includes healthcare providers in resource-limited settings, point-of-care testing facilities, and clinical laboratories seeking rapid and accurate infectious disease diagnostics.
Features
- Rapid results in 15-30 minutes, enabling timely clinical decisions
- Padlock probe technology for high specificity and accuracy
- Rolling circle amplification (RCA) for enhanced sensitivity
- Instrument-free operation, suitable for point-of-care settings
- Scalable production to meet high-volume demands
- Adaptable to new target variants through multiplex analyses
- Suitable for both rapid detection of several microorganisms in a sample or as a laboratory test for higher throughput